ObsEva Files Second Quarter 2022 Financial Statements

Rhea-AI Summary

ObsEva SA (NASDAQ: OBSV), a biopharmaceutical company, released its Second Quarter 2022 Financial Statements on August 17, 2022. The report highlights their ongoing commitment to developing therapies for women’s reproductive health, particularly focusing on preterm labor and IVF-related treatments. For further details, the financial statements are accessible on their website. ObsEva continues to pursue strategic in-licensing to enhance its clinical pipeline and improve pregnancy outcomes.

Positive

• Development of a clinical pipeline focused on women's reproductive health.
• Strategic in-licensing to enhance product offerings.

Negative

• None.

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange

Geneva, Switzerland and Boston, MA – August 17, 2022 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today published its Second Quarter 2022 Financial Statements. The Second Quarter 2022 Financial Statements may be found on the financial section of the Company’s website, here or directly via the link here.

About ObsEva

ObsEva is a biopharmaceutical company developing novel therapies to improve women’s reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a clinical pipeline with development programs focused on new therapies for the treatment of preterm labor and improving clinical pregnancy and live birth rates in women undergoing in vitro fertilization. ObsEva is listed on the Nasdaq Global Select Market and is traded under the ticker symbol “OBSV” and on the SIX Swiss Exchange where it is traded under the ticker symbol “OBSN”. For more information, please visit www.ObsEva.com.

For further information, please contact:

CEO Office Contact:
Shauna Dillon
Shauna.dillon@obseva.ch
+41 22 552 1550

Investor Contact:
Katja Bührer
Katja.buhrer@obseva.com
+1 (917) 969-3438

###

Attachment

• ObsEva_Q2 2022 Earnings Release_Pdf

FAQ

What financial results did ObsEva report for Q2 2022?

ObsEva published its Second Quarter 2022 Financial Statements on August 17, 2022, reflecting their ongoing efforts in women's reproductive health.

What is ObsEva's focus in drug development?

ObsEva is focused on developing novel therapies for preterm labor and improving clinical pregnancy rates in women undergoing IVF.

Where can I find ObsEva's Q2 2022 financial statements?

The Q2 2022 Financial Statements can be found on ObsEva's official website under the financial section.

What are ObsEva's stock symbols?

ObsEva is traded on the Nasdaq under the ticker symbol 'OBSV' and on the SIX Swiss Exchange as 'OBSN'.